- Library Home /
- Search Collections /
- Open Collections /
- Browse Collections /
- UBC Faculty Research and Publications /
- EMPA-REG OUTCOME Trial : What does it mean?
Open Collections
UBC Faculty Research and Publications
EMPA-REG OUTCOME Trial : What does it mean? Therapeutics Initiative (University of British Columbia)
Description
Therapeutics Letter 107 explores the findings of the EMP-REG trial. Conclusions: The EMPA-REG OUTCOME Trial tested the addition of empagliflozin to a ‘standard of care’ for T2DM whose impact on clinically important outcomes is currently unknown. It is uncertain whether the reduction in mortality and serious adverse events in the EMPA-REG OUTCOME Trial is attributable to empagliflozin or to less use of other glucose-lowering therapies. The results of this trial are not applicable to people with T2DM in other clinical settings. Until there is a body of evidence informed by large, independently conducted comparative effectiveness trials of different therapeutic strategies, we will not know the optimal treatment of T2DM at various stages of the diagnosis.
Item Metadata
Title |
EMPA-REG OUTCOME Trial : What does it mean?
|
Alternate Title |
Therapeutics Letter 107
|
Creator | |
Date Issued |
2017-08
|
Description |
Therapeutics Letter 107 explores the findings of the EMP-REG trial. Conclusions: The EMPA-REG OUTCOME Trial tested the addition of empagliflozin to a ‘standard of care’ for T2DM whose impact on clinically important outcomes is currently unknown. It is uncertain whether the reduction in mortality and serious adverse events in the EMPA-REG OUTCOME Trial is attributable to empagliflozin or to less use of other glucose-lowering therapies. The results of this trial are not applicable to people with T2DM in other clinical settings. Until there is a body of evidence informed by large, independently conducted comparative effectiveness trials of different therapeutic strategies, we will not know the optimal treatment of T2DM at various stages of the diagnosis.
|
Subject | |
Genre | |
Type | |
Language |
eng
|
Notes |
The UBC TI is funded by the BC Ministry of Health to provide evidence-based information about drug therapy. We neither formulate nor adjudicate provincial drug policies.
|
Date Available |
2023-06-20
|
Provider |
Vancouver : University of British Columbia Library
|
Rights |
Attribution-NonCommercial-NoDerivatives 4.0 International
|
DOI |
10.14288/1.0433686
|
URI | |
Affiliation | |
Peer Review Status |
Reviewed
|
Scholarly Level |
Faculty; Researcher
|
Rights URI | |
Aggregated Source Repository |
DSpace
|
Item Media
Item Citations and Data
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International